(PRWEB) February 26, 2014
His name is Claude and he is 26 years old. He was diagnosed with Stage II Malignant Melanoma in 2011. Treated with interferons to delay the recurrence of his disease, he was put on a one-year treatment with Intron A. The man-made drug naturally occurring in the human body to fight infection helped Claude succeed; he beat the cancer. Three years after his diagnosis, Claude is committed to helping others through this tough treatment. Together with the SteadyHealth team, he interviewed a group of patients who went through interferon treatment about their experiences, and he created a collection of the most useful links about interferons.
During the treatment, this brave young man suffered from side effects like headaches, nausea, fatigue, mild depression, hair thinning, muscle ache, fever, and chills. Before he started the interferon treatment, Claude did a lot of web research about the drug because, like many other patients, he didn’t know what exactly to expect. It was easy to find medical mumbo-jumbo texts about interferon, but they were also hard to interpret. Claude wanted to hear real patients’ stories. And that information wasn’t easily accessible.
When his treatment was over and he was fully recovered, Claude decided to share his story and the stories of patients he met during his cancer battle with other people. With the support of the SteadyHealth team, he created a collection of useful links about interferons, complete with short descriptions. In addition, Claude interviewed real people who went through interferon treatment or are still being treated now. He collected people's personal experiences about how they’re coping with their disease, interferon treatment and its side effects. Download Claude's Dealing With Interferon Side Effects: Patient Stories PDF ebook for free.
Claude will regularly be updating this document, and current and former patients who are interested in sharing their interferon story with others in need can send the team a message through the contact form link at the bottom of page, so they can be contacted for an interview.
At SteadyHealth, the team decided to support Claude’s efforts and help him publish and distribute his patient report. They believe this is a valuable and unbiased report for all who are preparing for or are already going through interferon treatment.